397 related articles for article (PubMed ID: 34419619)
1. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
Velez ML; Jordan CJ; Jansson LM
Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
[TBL] [Abstract][Full Text] [Related]
2. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
Velez ML; Jordan C; Jansson LM
Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
[TBL] [Abstract][Full Text] [Related]
3. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
4. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
Gersch H; Shah D; Chroust A; Bailey B
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
[TBL] [Abstract][Full Text] [Related]
5. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
[TBL] [Abstract][Full Text] [Related]
6. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
[TBL] [Abstract][Full Text] [Related]
7. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
Mills-Huffnagle S; Nyland JE
BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
[TBL] [Abstract][Full Text] [Related]
9. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome?
Wachman EM
J Addict Med; 2020; 14(2):93-94. PubMed ID: 31149916
[TBL] [Abstract][Full Text] [Related]
10. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
[TBL] [Abstract][Full Text] [Related]
11. Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.
Mahnke AH; Roberts MH; Leeman L; Ma X; Bakhireva LN; Miranda RC
Sci Rep; 2022 Apr; 12(1):5941. PubMed ID: 35396369
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
[TBL] [Abstract][Full Text] [Related]
13. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Abstinence Syndrome: Prevention, Recognition, Treatment, and Follow-up.
Schroeder M; White J
S D Med; 2021 Dec; 74(12):576-583. PubMed ID: 35015949
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of auricular acupressure as an adjunct treatment for neonatal opioid withdrawal syndrome (NOWS).
Jackson HJ; Lopez C; Miller S; Englehardt B
Subst Abus; 2021; 42(3):348-357. PubMed ID: 32635829
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome: An Ecological View of Non-Pharmacologic Interventions for Feeding Success.
Cardin AD
Crit Care Nurs Clin North Am; 2024 Jun; 36(2):235-249. PubMed ID: 38705691
[TBL] [Abstract][Full Text] [Related]
17. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
Isaac L; van den Hoogen NJ; Habib S; Trang T
J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
[TBL] [Abstract][Full Text] [Related]
18. Neonatal Opioid Withdrawal Syndrome: A Developmental Care Approach.
Piccotti L; Voigtman B; Vongsa R; Nellhaus EM; Rodriguez KJ; Davies TH; Quirk S
Neonatal Netw; 2019 May; 38(3):160-169. PubMed ID: 31470383
[TBL] [Abstract][Full Text] [Related]
19. Transitioning Care Approach for Neonatal Opioid Withdrawal Syndrome and Neonatal Abstinence Syndrome.
Perez C
Crit Care Nurs Clin North Am; 2024 Jun; 36(2):223-233. PubMed ID: 38705690
[TBL] [Abstract][Full Text] [Related]
20. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
